Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 246 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN | 75MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 342 |
APO-IRBESARTAN | 300MG | TABLET | Resolved | 2018-05-15 | 2018-09-11 | 49408 |
APO-IRBESARTAN | 150MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55788 |
APO-IRBESARTAN | 75MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55791 |
APO-IRBESARTAN | 300MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55810 |
APO-IRBESARTAN | 75MG | TABLET | Actual shortage | 2018-11-09 | 2018-11-09 | 66534 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 345 |
APO-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 351 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2017-10-11 | 2017-11-15 | 25287 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-10 | 354 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-02 | 2017-06-27 | 8602 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-25 | 2018-02-23 | 16871 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-25 | 2017-09-25 | 16874 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-05-22 | 2018-08-09 | 50044 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-02-26 | 2020-03-27 | 107199 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-06-06 | 2024-06-06 | 229755 |
APO-KETOCONAZOLE | 200MG | TABLET | Resolved | 2018-01-17 | 2018-07-23 | 36295 |
APO-KETOCONAZOLE | 200MG | TABLET | Resolved | 2020-08-12 | 2020-09-01 | 122065 |
APO-KETOROLAC | 10MG | TABLET | Resolved | 2021-04-23 | 2021-05-17 | 137959 |
APO-KETOROLAC | 10MG | TABLET | Resolved | 2024-03-01 | 2024-04-19 | 221084 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |